Cargando…
Targeted Therapy for Pulmonary Hypertension in Premature Infants
Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, the...
Autores principales: | Nees, Shannon N., Rosenzweig, Erika B., Cohen, Jennifer L., Valencia Villeda, Gerson A., Krishnan, Usha S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464771/ https://www.ncbi.nlm.nih.gov/pubmed/32824244 http://dx.doi.org/10.3390/children7080097 |
Ejemplares similares
-
Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study
por: Rosenzweig, Eliana, et al.
Publicado: (2023) -
Chronic Thromboembolic Pulmonary Hypertension in a Child With Sickle Cell Disease
por: Spencer, Robert, et al.
Publicado: (2020) -
Pulmonary artery thromboembolism in a critically ill neonate successfully treated using thrombolytic therapy
por: Villeda, Gerson Valencia, et al.
Publicado: (2021) -
Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022) -
Portopulmonary hypertension in children: a rare but potentially lethal and under-recognized disease
por: Tingo, Jennifer, et al.
Publicado: (2017)